...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >An in vivo model of double-unit cord blood transplantation that correlates with clinical engraftment.
【24h】

An in vivo model of double-unit cord blood transplantation that correlates with clinical engraftment.

机译:与临床植入相关的双单位脐带血移植的体内模型。

获取原文
获取原文并翻译 | 示例

摘要

Double-unit cord blood transplantation (DCBT) appears to enhance engraftment despite sustained hematopoiesis usually being derived from a single unit. To investigate DCBT biology, in vitro and murine models were established using cells from 39 patient grafts. Mononuclear cells (MNCs) and CD34(+) cells from each unit alone and in DCB combination were assessed for colony-forming cell and cobblestone area-forming cell potential, and multilineage engraftment in NOD/SCID/IL2R-gamma(null) mice. In DCB assays, the contribution of each unit was measured by quantitative short tandem repeat region analysis. There was no correlation between colony-forming cell (n = 10) or cobblestone area-forming cell (n = 9) numbers and clinical engraftment, and both units contributed to DCB cocultures. In MNC transplantations in NOD/SCID/IL2R-gamma(null) mice, each unit engrafted alone, but MNC DCBT demonstrated single-unit dominance that correlated with clinical engraftment in 18 of 21 cases (86%, P < .001). In contrast, unit dominance and clinical correlation were lost with CD34(+) DCBT (n = 11). However, add-back of CD34(-) to CD34(+) cells (n = 20) restored single-unit dominance with the dominant unit correlating not with clinical engraftment but also with the origin of the CD34(-) cells in all experiments. Thus, unit dominance is an in vivo phenomenon probably associated with a graft-versus-graft immune interaction mediated by CD34(-) cells.
机译:尽管通常来自单个单位的持续造血作用,但双单位脐带血移植(DCBT)似乎增强了植入。为了研究DCBT生物学,使用来自39个患者移植物的细胞建立了体外和鼠模型。评估每个单元单独和DCB组合中的单核细胞(MNCs)和CD34(+)细胞的集落形成细胞和鹅卵石形成区域的细胞潜力,以及在NOD / SCID /IL2R-γ(null)小鼠中多系移植的情况。在DCB分析中,每个单元的贡献通过定量的短串联重复序列区域分析来测量。集落形成细胞(n = 10)或鹅卵石区域形成细胞(n = 9)的数目与临床植入之间没有相关性,并且两个单位都有助于DCB共培养。在NOD / SCID / IL2R-gamma(null)小鼠的MNC移植中,每个单位都单独植入,但MNC DCBT在21例病例中有18例表现出与临床植入相关的单单位优势(86%,P <.001)。相反,CD34(+)DCBT(n = 11)失去了单位优势和临床相关性。但是,在所有实验中,将CD34(-)加回到CD34(+)细胞(n = 20)可以恢复单一单位的优势,而优势单位与临床植入无关,而且与CD34(-)细胞的起源无关。因此,单位优势是一种体内现象,可能与CD34(-)细胞介导的移植物抗移植物免疫相互作用有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号